Artificial Pancreas Market by Type and Geography - Forecast and Analysis 2022-2026

  • Published: Jan 2022
  • Pages: 120
  • SKU: IRTNTR72088

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The artificial pancreas market share is expected to increase by USD 450.95 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 19.15%.

This artificial pancreas market research report extensively covers artificial pancreas market segmentation by type (threshold suspend device, non-threshold suspend device, control to range system, and control to target system) and geography (North America, Europe, Asia, and ROW). The artificial pancreas market report also offers information on several market vendors, including Admetsys Corp., Beta Bionics Inc., Bigfoot Biomedical Inc., Defymed SAS, Dexcom Inc., Inreda Diabetic B.V., Insulet Corp., Medtech Life Pvt. Ltd., Medtronic Plc, and Tandem Diabetes Care Inc. among others.

What will the Artificial Pancreas Market Size be During the Forecast Period?

Artificial Pancreas Market Size

Download the Free Report Sample to Unlock the Artificial Pancreas Market Size for the Forecast Period and Other Important Statistics


Artificial Pancreas Market: Key Drivers, Trends, and Challenges

The rising global burden of diabetes is notably driving the artificial pancreas market growth, although factors such as stringent regulatory framework may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the artificial pancreas industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Artificial Pancreas Market Driver

One of the key factors driving growth in the artificial pancreas market is the rising global burden of diabetes. Diabetes is a chronic disease, which occurs when the body cannot use insulin effectively or when the pancreas does not produce enough insulin. Hyperglycemia or increased blood sugar can result in severe damage or complications that may become life-threatening for the individual if left untreated. The global burden of the disease is rising at a rapid pace. The growing incidence of both type 1 and type 2 diabetes will significantly increase healthcare costs across the world. The factors contributing to the increase in the diabetic population include obesity, smoking, a sedentary lifestyle, and growing urbanization. Furthermore, the incidence of diabetes is higher in the case of the older population. Countries with a higher population base like China and India are likely to have a higher incidence of diabetes owing to an increase in obesity levels and urbanization. Thus, the increasing incidence of diabetes worldwide is likely to drive the market with the increased adoption of an artificial pancreas.

Key Artificial Pancreas Market Trend

The increase in awareness programs for diabetes is another factor supporting the artificial pancreas market share growth. Vendors are organizing summits to spread awareness about diabetes as well as generate insights for product development. For instance, the European Foundation for the Study of Diabetes (EFSD) in Europe is a leading European funding agency for diabetes research, which aims at creating and spreading awareness of type 1 diabetes among people. The Juvenile Diabetes Research Foundation (JDRF) is fighting type 1 diabetes by funding research, advocating for policies that improve patient access to drugs, and providing a single support network for patients with type 1 diabetes. Various initiatives taken to increase the awareness of diabetes management in the region will also accelerate the growth of the market during the forecast period. Such initiatives provide participants with knowledge of various tools and daily routine activities for diabetes prevention, management, and control. This will further enhance the demand for artificial pancreas among diabetic patients, which, in turn, will drive the growth of the market.

Key Artificial Pancreas Market Challenge

The stringent regulatory framework will be a major challenge for the artificial pancreas market during the forecast period. Medical device-related regulations must be improved to ensure that high-quality, efficient, and safe technologies reach consumers. The growing number and modernization of medical devices have led to new regulatory challenges. The US FDA has classified diabetes care management devices, such as insulin pumps, infusion sets, and insulin bolus, under the Class II category of medical devices. Failure to adhere to the US FDA regulations or any complications caused by the use of artificial pancreas will lead to the recall of the product, which will significantly affect the company's brand name. In Europe and the US, regulations, including those for medical devices, focus on deploying robust surveillance systems, enhancing post-market regulations, strengthening the regulatory process, and improving monitoring of such devices. Market vendors that are focusing on adopting innovative technologies and designing novel products should undergo stringent post-market approvals prior to the launch of the products. Therefore, the stringent regulatory scenario could potentially hamper the artificial pancreas market.

This artificial pancreas market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global artificial pancreas market as a part of the global healthcare supplies market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the artificial pancreas market during the forecast period.

Who are the Major Artificial Pancreas Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:


  • Admetsys Corp.
  • Beta Bionics Inc.
  • Bigfoot Biomedical Inc.
  • Defymed SAS
  • Dexcom Inc.
  • Inreda Diabetic B.V.
  • Insulet Corp.
  • Medtech Life Pvt. Ltd.
  • Medtronic Plc
  • Tandem Diabetes Care Inc.


This statistical study of the artificial pancreas market encompasses successful business strategies deployed by the key vendors. The artificial pancreas market is concentrated and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Product Insights and News

  • Admetsys Corp - The company offers artificial pancreas such as the closed-loop artificial pancreas.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The artificial pancreas market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Artificial Pancreas Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the artificial pancreas market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chains is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

The value chain of the healthcare supplies market includes the following core components:

  • R&D
  • Inputs
  • Operations
  • Outbound logistics
  • Marketing and sales
  • Post-sales and services
  • Industry innovations

The report has further elucidated on other innovative approaches being followed by manufacturers to ensure a sustainable market presence.

Which are the Key Regions for Artificial Pancreas Market?

Artificial Pancreas Market Market segmentation by region

For more insights on the market share of various regions Request for a FREE sample now!

43% of the market's growth will originate from North America during the forecast period. The US is the key market for artificial pancreas in North America. Market growth in this region will be slower than the growth of the market in the European and Asian regions.

The increase in technological advances and a high incidence of type 1 and type 2 diabetes will facilitate the artificial pancreas market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The outbreak of COVID-19 adversely affected all the countries in North America, especially the US, in 2020. However, it had only a slightly negative impact on the artificial pancreas market in North America. By the second half of 2020, the lockdown-related restrictions were somewhat relaxed in various countries, which included the resumption of businesses and non-essential services. Thus, the resumption of healthcare equipment manufacturing will cater to the demand for artificial pancreas in North America through both online and offline channels, and the market in focus will register an accelerating growth momentum during the forecast period

What are the Revenue-generating Type Segments in the Artificial Pancreas Market?

Artificial Pancreas Market Segmentation

To gain further insights on the market contribution of various segments Request for a FREE sample

The artificial pancreas market share growth by the threshold suspend device segment will be significant during the forecast period. Threshold suspend is a Continuous Glucose Monitor (CGM) enabled feature that is designed to automatically stop insulin delivery when the sensor value reaches or falls below a pre-set threshold. This increases the demand for threshold suspends device systems among diabetic patients. Therefore the segment is expected to grow during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the artificial pancreas market size and actionable market insights on post COVID-19 impact on each segment.


Artificial Pancreas Market Scope

Report Coverage


Page number


Base year


Forecast period


Growth momentum & CAGR

Accelerate at a CAGR of 19.15%

Market growth 2022-2026

$ 450.95 million

Market structure


YoY growth (%)


Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 43%

Key consumer countries

US, Germany, France, China, and UK

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Admetsys Corp., Beta Bionics Inc., Bigfoot Biomedical Inc., Defymed SAS, Dexcom Inc., Inreda Diabetic B.V., Insulet Corp., Medtech Life Pvt. Ltd., Medtronic Plc, and Tandem Diabetes Care Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Artificial Pancreas Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive artificial pancreas market growth during the next five years
  • Precise estimation of the artificial pancreas market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the artificial pancreas industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of artificial pancreas market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1. Executive Summary                           

                1.1     Market Overview            

                                Exhibit 01:  Key Finding 1

                                Exhibit 02:  Key Finding 2

                                Exhibit 03:  Key Finding 3

                                Exhibit 04:  Key Finding 5

                                Exhibit 05:  Key Finding 6

                                Exhibit 06:  Key Finding 7

                                Exhibit 07:  Key Finding 8

2. Market Landscape

                2.1 Market ecosystem             

                                2.1.1 Parent Market

                                Exhibit 08  Parent market

                                Exhibit 09:  Market characteristics

                2.2 Value Chain Analysis          

                                Exhibit 10:  Value Chain Analysis: Healthcare Supplies

                                2.2.1    R&D

                                2.2.2    Inputs

                                2.2.3    Operations

                                2.2.4    Outbound logistics

                                2.2.5    Marketing and sales

                                2.2.6    Post-sales and services

                                2.2.7    Industry innovations

3. Market Sizing                       

                3.1 Market definition

                                Exhibit 11:  Offerings of vendors included in the market definition

                3.2 Market segment analysis 

                                Exhibit 12:  Market segments

                3.3 Market size 2021 

                3.4 Market outlook: Forecast for 2021 - 2026 

                                3.4.1Estimating growth rates for emerging and high-growth markets

                                3.4.2Estimating growth rates for mature markets

                                Exhibit 13:  Global - Market size and forecast 2021 - 2026 ($ million)

                                Exhibit 14:  Global market: Year-over-year growth 2021 - 2026 (%)

4. Five Forces Analysis                          

                4.1 Five Forces Summary        

                                Exhibit 15:  Five forces analysis 2021 - 2026

                4.2 Bargaining power of buyers           

                                Exhibit 16: Bargaining power of the buyer

                4.3 Bargaining power of suppliers       

                                Exhibit 17: Bargaining power of the supplier

                4.4 Threat of new entrants    

                                Exhibit 18: Threat of new entrants

                4.5 Threat of substitutes         

                                Exhibit 19: Threat of substitutes

                4.6 Threat of rivalry   

                                Exhibit 20: Threat of rivalry

                4.7 Market condition

                                Exhibit 21: Market condition - Five forces 2021

5. Market Segmentation by  Type

                5.1 Market segments

                                Exhibit 22:  Type- Market share 2021 - 2026 (%)

                5.2 Comparison by Type          

                                Exhibit 23:  Comparison by Type

                5.3 Threshold suspend device - Market size and forecast 2021-2026     

                                Exhibit 24:  Threshold suspend device - Market size and forecast 2021-2026 ($ million)

                                Exhibit 25:  Threshold suspend device - Year-over-year growth 2021-2026 (%)

                5.4 Non-threshold suspend device - Market size and forecast 2021-2026            

                                Exhibit 26:  Non-threshold suspend device - Market size and forecast 2021-2026 ($ million)

                                Exhibit 27:  Non-threshold suspend device - Year-over-year growth 2021-2026 (%)

                5.5 Control to range system - Market size and forecast 2021-2026         

                                Exhibit 28:  Control to range system  - Market size and forecast 2021-2026 ($ million)

                                Exhibit 29:  Control to range system  - Year-over-year growth 2021-2026 (%)

                5.6 Control to target system - Market size and forecast 2021-2026        

                                Exhibit 30:  Control to target system - Market size and forecast 2021-2026 ($ million)

                                Exhibit 31:  Control to target system - Year-over-year growth 2021-2026 (%)

                5.7 Market opportunity by Type          

                                Exhibit 32:  Market opportunity by Type

6. Customer landscape                         

                                Technavio’s customer landscape matrix comparing Drivers or price sensitivity, Adoption lifecycle, importance in customer price basket, Adoption rate and Key purchase criteria

                6.1 Overview

                                Exhibit 33:  Customer landscape

7. Geographic Landscape                     

                7.1 Geographic segmentation

                                Exhibit 34:  Market share by geography 2021-2026 (%)

                7.2 Geographic comparison   

                                Exhibit 35:  Geographic comparison

                7.3 North America - Market size and forecast 2021-2026           

                                Exhibit 36:  North America - Market size and forecast 2021-2026 ($ million)

                                Exhibit 37:  North America - Year-over-year growth 2021-2026 (%)

                7.4 Europe - Market size and forecast 2021-2026          

                                Exhibit 38:  Europe - Market size and forecast 2021-2026 ($ million)

                                Exhibit 39:  Europe - Year-over-year growth 2021-2026 (%)

                7.5 Asia - Market size and forecast 2021-2026

                                Exhibit 40:  Asia - Market size and forecast 2021-2026 ($ million)

                                Exhibit 41:  Asia - Year-over-year growth 2021-2026 (%)

                7.6 ROW - Market size and forecast 2021-2026              

                                Exhibit 42:  ROW  - Market size and forecast 2021-2026 ($ million)

                                Exhibit 43:  ROW - Year-over-year growth 2021-2026 (%)

                7.7 Key leading countries        

                                Exhibit 44:  Key leading countries

                7.8 Market opportunity by geography

                                Exhibit 45:  Market opportunity by geography ($ million)

8. Drivers, Challenges, and Trends                   

                8.1 Market drivers     

                                8.1.1    Rising global burden of diabetes

                                Exhibit 46:  Prevalence of diabetes 2000 and 2030 (million)

                                8.1.2    Favorable regulations and guidelines

                                8.1.3    Rising geriatric population

                8.2 Market challenges              

                                8.2.1    Stringent regulatory framework

                                8.2.2    Low penetration rates

                                8.2.3    High cost of artificial pancreas

                                Exhibit 47:  Impact of drivers and challenges

                8.3 Market trends      

                                8.3.1    Increase in awareness programs for diabetes     

                                8.3.2    Growing technological integration

                                8.3.3    Rising strategic partnerships to boost sales of artificial pancreas

9. Vendor Landscape                             

                9.1 Overview

                                Exhibit 48:  Vendor landscape

                9.2 Landscape disruption        

                                Exhibit 49:  Landscape disruption

                                Exhibit 50: Industry Risk

10. Vendor Analysis               

                10.1 Vendors covered              

                                Exhibit 51: Vendors covered

                10.2 Market positioning of vendors    

                                Exhibit 52: ?Market positioning of vendors?

                10.3 Admetsys Corp.

                                Exhibit 53:  Admetsys Corp. - Overview

                                Exhibit 54:  Admetsys Corp. - Product and service

                                Exhibit 55:  Admetsys Corp. - Key offerings

                10.4 Beta Bionics Inc.

                                Exhibit 56:  Beta Bionics Inc. - Overview

                                Exhibit 57:  Beta Bionics Inc. - Business segments

                                Exhibit 58:  Beta Bionics Inc. - Key news

                                Exhibit 59:  Beta Bionics Inc. - Key offerings

                                Exhibit 60:  Beta Bionics Inc. - Segment focus

                10.5 Bigfoot Biomedical Inc.  

                                Exhibit 61:  Bigfoot Biomedical Inc. - Overview

                                Exhibit 62:  Bigfoot Biomedical Inc. - Product and service

                                Exhibit 63:  Bigfoot Biomedical Inc. - Key offerings

                10.6 Defymed SAS     

                                Exhibit 64:  Defymed SAS - Overview

                                Exhibit 65:  Defymed SAS - Product and service

                                Exhibit 66:  Defymed SAS - Key offerings

                10.7 Dexcom Inc.        

                                Exhibit 67:  Dexcom Inc. - Overview

                                Exhibit 68:  Dexcom Inc. - Business segments

                                Exhibit 69:  Dexcom Inc. - Key offerings

                                Exhibit 70:  Dexcom Inc. - Segment focus

                10.8 Inreda Diabetic B.V.         

                                Exhibit 71:  Inreda Diabetic B.V. - Overview

                                Exhibit 72:  Inreda Diabetic B.V. - Product and service

                                Exhibit 73:  Inreda Diabetic B.V. - Key offerings

                10.9 Insulet Corp.       

                                Exhibit 74:  Insulet Corp. - Overview

                                Exhibit 75:  Insulet Corp. - Business segments\

                                Exhibit 76:  Insulet Corp. - Key offerings

                                Exhibit 77:  Insulet Corp. - Segment focus

                10.10 Medtech Life Pvt. Ltd.  

                                Exhibit 78:  Medtech Life Pvt. Ltd. - Overview

                                Exhibit 79:  Medtech Life Pvt. Ltd. - Product and service

                                Exhibit 80:  Medtech Life Pvt. Ltd. - Key offerings

                10.11 Medtronic Plc  

                                Exhibit 81:  Medtronic Plc - Overview

                                Exhibit 82:  Medtronic Plc - Business segments

                                Exhibit 83:  Medtronic Plc - Key offerings

                                Exhibit 84:  Medtronic Plc - Segment focus

                10.12 Tandem Diabetes Care Inc.        

                                Exhibit 85:  Tandem Diabetes Care Inc. - Overview

                                Exhibit 86:  Tandem Diabetes Care Inc. - Business segments

                                Exhibit 87:  Tandem Diabetes Care Inc. - Key offerings

                                Exhibit 88:  Tandem Diabetes Care Inc. - Segment focus

11. Appendix                            

                11.1 Scope of the report         

                                11.1.1 ????Market definition

                                11.1.2 ????Objectives

                                11.1.3 ????Notes and caveats

                11.2 Currency conversion rates for US$            

                                Exhibit 89: ?Currency conversion rates for US$?

                11.3 Research Methodology 

                                Exhibit 90: ?Research Methodology

                                Exhibit 91: ??Validation techniques employed for market sizing?

                                Exhibit 92: ??Information sources

                11.4 List of abbreviations        

                                Exhibit 93: List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.


Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases


Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts



  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis


  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
Artificial Pancreas market growth will increase by $450.95 million during 2021-2026.
The artificial pancreas market is expected to grow at a CAGR of 19.15% during 2021-2026.
Technavio has segmented the artificial pancreas market by type (Threshold suspend device, Non-threshold suspend device, Control to range system, and Control to target system) and geographic (North America, Europe, Asia, and ROW).
Admetsys Corp., Beta Bionics Inc., Bigfoot Biomedical Inc., Defymed SAS, Dexcom Inc., Inreda Diabetic B.V., Insulet Corp., Medtech Life Pvt. Ltd., Medtronic Plc, Tandem Diabetes Care Inc. are a few of the key vendors in the artificial pancreas market.
North America will register the highest growth rate of 42.88% among the other regions. Therefore, the artificial pancreas market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
The key factors driving the artificial pancreas market growth are:
  • Rising global burden of diabetes
The artificial pancreas market vendors should focus on grabbing business opportunities from the threshold suspend device segment as it accounted for the largest market share in the base year.
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO recognized

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted

  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>